These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15701433)

  • 1. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
    Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
    J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
    J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
    Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
    J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
    Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
    J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
    Gorlitzer M; Ankersmit J; Fiegl N; Meinhart J; Lanzenberger M; Unal K; Dunkler D; Kilo J; Wolner E; Grimm M; Grabenwoeger M
    Transpl Int; 2005 Apr; 18(4):390-5. PubMed ID: 15773956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
    Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
    G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
    Bourge RC; Kirklin JK; Naftel DC; White C; Mason DA; Epstein AE
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
    Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
    Chang PP; Longenecker JC; Wang NY; Baughman KL; Conte JV; Hare JM; Kasper EK
    J Heart Lung Transplant; 2005 Aug; 24(8):998-1007. PubMed ID: 16102433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.
    Torres Macho J; Delgado Jimenez JF; Sanz Salvo J; Gonzalez Mansilla A; Sanchez Sanchez V; Gamez Diez S; Escribano Subias P; Saenz de la Calzada C
    Transplant Proc; 2009; 41(6):2477-9. PubMed ID: 19715956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year.
    Chau EM; Bailey KR; Mahoney DW; Frantz RP; McGregor CG; Daly RC; Edwards BS; Olson LJ; Rodeheffer RJ
    Circulation; 1996 Nov; 94(9 Suppl):II267-72. PubMed ID: 8901758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. The CASCADE Investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants.
    Carrier M; Rivard M; Latter D; Kostuk W
    Can J Cardiol; 1998 May; 14(5):703-7. PubMed ID: 9627527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
    Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.